9
Views
10
CrossRef citations to date
0
Altmetric
Articles

Is There a Role for Adjuvant Immunochemotherapy after Radical Nephrectomy in pT2-3N0M0 Renal Cell Carcinoma?

Pages 240-245 | Published online: 18 Jul 2013

REFERENCES

  • Golimbu M, Joshi P, Sperberg A, Tessler A, Al-Askari S, Morales P. Renal cell carcinoma: survival and prognostic factors. Urology, 1986; 27 (4): 291–301.
  • Giuliani L, Giberti C, Martorana G, Rovida S. Radical extensive surgery for renal cell carcinoma. Long term results and prognostic factors. Urology 1990; 143: 468–473.
  • Robson CJ, Churchill B, Anderson W. Radical nephrectomy for renal cell carcinoma. J Urol 1969; 301: 297–301.
  • Skinner DG, Colvin RB, Vermillion CD, Pfister RC, Leadbetter WF. Diagnosis and management of renal cell carcinoma: a clinical and pathologic study of 309 cases. Cancer, 1971; 28: 1165-1177.
  • Tsukamoto T, Kumamoto Y, Miyao N, Yamazaky K, Takahashi A, Satoh M. Regional lymph node metastasis in renal cell carcinoma: incidence, distribution and its relation to other pathologic findings. Eur Urol 1990; 18: 88–93.
  • Fisher ER, Swamidoss S, Lee CH. Detection and significance of occult axillary metastases in patients with invasive breast cancer. Cancer, 1978; 42: 2025–2031.
  • Figlin RA, De Kernion JB, Maldzus J, Sama G. Treatment of renal cell carcinoma with alpha human leukocyte interferon and vinblastine combination: a phase I-II trial. Cancer Treat Rep 1985; 69: 263–267.
  • Fossa SD, De Garis ST, Heier MS. Recombinant interferon alpha-2a with or without vinblastine in metastatic renal cell carcinoma. Cancer 1986; (Suppl.) 57: 1700-1704.
  • Palmer PA, Vinke J, Philip T, Negrier S, Atzpodien J. Prognostic factors for survival in patients with advanced renal cell carcinoma treated with recombinant interleukin-2. Ann Oncol 1992; 3: 475–480.
  • Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457–481.
  • Peto R, Peto J. Asymptomatically efficient rank invari-ant test procedures. J Roy Stat Soc 1972; 135: 185–206.
  • Pizzocaro G, Di Fronzo G, Piva L. Adjuvant medroxy-progesterone acetate to radical nephrectomy in category Mo renal cell carcinoma. Eur Urol 1983; 9: 202–206.
  • Finney R. An evaluation of postoperative radiotherapy in hypernephroma treatment. A clinical trial. Cancer 1973; 32: 1056–1061.
  • Burnet FM. The concept of immunological surveillance. Prog Exp Tumor Res 1970; 13: 1–15.
  • Bergerat JP, Defour P, Soyer Y, BoRack C, Jacqmin D. Traitement des adenocarcinomes renaux metastatiques par l'association interferon recombinant alpha-2a et vinblastine. Presse Med. 1987; 16, 39: 1953–1956.
  • Neidhart JA, Gagen MM, Young D. Interferon alpha therapy of renal cancer. Cancer Res 1984; 44: 4140–4143.
  • Storkel S, Thones W, Jacobi GH, Lippold R. Prognostic parameters in renal cell carcinoma—a new approach. Eur Urol 1989; 16 (6): 416–422.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.